Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Exagen (NASDAQ:XGN) through any online brokerage.
Other companies in Exagen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Exagen has a consensus price target of $9.25.
The stock price for Exagen (NASDAQ: XGN) is $8.105 last updated October 1, 2026 at 10:08 AM EDT.
There are no upcoming dividends for Exagen.
Exagen does not have any upcoming earnings scheduled.
There is no upcoming split for Exagen.
Exagen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.